157 related articles for article (PubMed ID: 30972946)
1. CCDN1 rs603965 polymorphism may serve as a genetic biomarker of brain tumor: A meta-analysis of 5,769 subjects.
Lan J; Li M; Wang H
Mol Genet Genomic Med; 2019 Jun; 7(6):e00655. PubMed ID: 30972946
[TBL] [Abstract][Full Text] [Related]
2. The CCND1 G870A gene polymorphism and brain tumor risk: a meta-analysis.
Qin LY; Zhao LG; Chen X; Li P; Yang Z; Mo WN
Asian Pac J Cancer Prev; 2014; 15(8):3607-12. PubMed ID: 24870765
[TBL] [Abstract][Full Text] [Related]
3. Association between
Thakur N; Kumari S; Mehrotra R
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30361291
[No Abstract] [Full Text] [Related]
4. Association between the G870A polymorphism of Cyclin D1 gene and glioma risk.
Zong H; Cao L; Ma C; Zhao J; Ming X; Shang M; Xu H
Tumour Biol; 2014 Aug; 35(8):8095-101. PubMed ID: 24840634
[TBL] [Abstract][Full Text] [Related]
5. The rs498872 polymorphism is associated with an elevated susceptibility to glioma: a meta-analysis of 36,264 subjects.
Chen B; Li Y; Chen L; Du Y
Acta Neurol Belg; 2019 Jun; 119(2):239-243. PubMed ID: 30684220
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 (CCND1) G870A polymorphisms and cervical cancer susceptibility: a meta-analysis based on ten case-control studies.
Wu Y; Fu H; Zhang H; Huang H; Chen M; Zhang L; Yang H; Qin D
Tumour Biol; 2014 Jul; 35(7):6913-8. PubMed ID: 24737585
[TBL] [Abstract][Full Text] [Related]
7. Impact of interaction between the G870A and EFEMP1 gene polymorphism on glioma risk in Chinese Han population.
Yang L; Qu B; Xia X; Kuang Y; Li J; Fan K; Guo H; Zheng H; Ma Y
Oncotarget; 2017 Jun; 8(23):37561-37567. PubMed ID: 28380465
[TBL] [Abstract][Full Text] [Related]
8. Association between cyclin D1 (CCND1) G870A polymorphism and gastric cancer risk: a meta-analysis.
Zhang Y; Zeng X; Lu H; Ji H; Zhao E; Li Y
Oncotarget; 2016 Oct; 7(40):66109-66118. PubMed ID: 27623072
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a case-control study and meta-analysis.
Liao D; Wu Y; Pu X; Chen H; Luo S; Li B; Ding C; Huang GL; He Z
PLoS One; 2014; 9(11):e113299. PubMed ID: 25409185
[TBL] [Abstract][Full Text] [Related]
10. Association between Cyclin D1 polymorphism and oral cancer susceptibility: a meta-analysis.
Wang L; Wang Z; Gao X; Li X; Sun X; Liu C
Tumour Biol; 2014 Feb; 35(2):1149-55. PubMed ID: 24186074
[TBL] [Abstract][Full Text] [Related]
11. The association between CCND1 G870A polymorphism and colorectal cancer risk: A meta-analysis.
Xie M; Zhao F; Zou X; Jin S; Xiong S
Medicine (Baltimore); 2017 Oct; 96(42):e8269. PubMed ID: 29049220
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis on associations of IL-6 and IL-10 polymorphisms with susceptibility to ischemic stroke.
Chen M; Yang Y
J Neuroimmunol; 2019 Oct; 335():577004. PubMed ID: 31446341
[TBL] [Abstract][Full Text] [Related]
13. CCND1 G870A polymorphism with altered cyclin D1 transcripts expression is associated with the risk of glioma in a Chinese population.
Chen X; Zhao T; Li L; Xu C; Zhang X; Tse V; Zhang T; Liu X; Lu F
DNA Cell Biol; 2012 Jun; 31(6):1107-13. PubMed ID: 22304571
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 (CCND1) G870A gene polymorphism is an ethnicity-dependent risk factor for digestive tract cancers: a meta-analysis comprising 20,271 subjects.
Chen B; Cao L; Yang P; Zhou Y; Wu XT
Cancer Epidemiol; 2012 Apr; 36(2):106-15. PubMed ID: 21606015
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 polymorphism and oral cancer: a meta-analysis.
Wang W; Zhao Y; Yang J; Lin B; Gu H; Cao X; Ge L
Mol Biol Rep; 2013 Jan; 40(1):87-95. PubMed ID: 23111452
[TBL] [Abstract][Full Text] [Related]
16. Association of ERCC1 C8092A and ERCC2 Lys751Gln polymorphisms with the risk of glioma: a meta-analysis.
Xin Y; Hao S; Lu J; Wang Q; Zhang L
PLoS One; 2014; 9(4):e95966. PubMed ID: 24763305
[TBL] [Abstract][Full Text] [Related]
17. Association between cyclin D1 G870A polymorphism and cervical cancer risk: a cumulative meta-analysis involving 2,864 patients and 3,898 controls.
Hu YY; Zheng R; Guo C; Niu YM
Diagn Pathol; 2014 Sep; 9():168. PubMed ID: 25204741
[TBL] [Abstract][Full Text] [Related]
18. Effect of CDKN2A/B rs4977756 polymorphism on glioma risk: a meta-analysis of 16 studies including 24077 participants.
Qi X; Wan Y; Zhan Q; Yang S; Wang Y; Cai X
Mamm Genome; 2016 Feb; 27(1-2):1-7. PubMed ID: 26577493
[TBL] [Abstract][Full Text] [Related]
19. CCND1 rs9344 polymorphism is associated with the risk of hepatocellular carcinoma in Caucasian population.
Wang DD; Duan WD; Zhu ZM; Tu YL; Dou CQ; Han MM; Zhang B; Zhao W; Jiang K
J Cancer Res Ther; 2018 Jun; 14(Supplement):S516-S518. PubMed ID: 29970717
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 G870A polymorphism and lung cancer risk: a meta-analysis.
Liu J; Liao Q; Zhang Y; Sun S; Zhong C; Liu X
Tumour Biol; 2012 Oct; 33(5):1467-76. PubMed ID: 22528945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
